US equities |
NVDA $239.78 ▲+2.49% SPCX $169.48 ▲+6.62% MU $1,061.47 ▼-1.25% TSLA $380.83 ▲+2.76% SNDK $1,693.66 ▼-1.53% MSFT $528.32 ▲+2.08% INTC $116.40 ▼-2.46% META $742.85 ▲+2.03%
FinancialContent

Zenas BioPharma, Inc. - Common Stock (NQ:ZBIO)

27.95 -0.35 (-1.24%)
Delayed Quote Updated: 3:15 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zenas BioPharma, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Week In Review: Zenas Raises $259 Million In IPO ↗
It was a quiet week for biotech news in the Chinese market. Here is a brief overview of the notable events that occurred during this time. Zenas BioPharma staged a rare US biopharma IPO worth $259... 
Via Talk Markets
Topics Initial Public Offering
News headline image
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
From Zenas BioPharma
Via GlobeNewswire
News headline image
Trio Of Biotech IPOs Climb In Debut ↗
A trio of biotech companies' shares rose on Friday in their first trading sessions. Bicara Therapeutics, MBX Biosciences, and Zenas BioPharma each sold more shares in their respective initial public... 
Via Talk Markets
< Previous 1 2 3 4 5 Next >